Coffee consumption decreases risks for hepatic Fibrosis and Cirrhosis: A Meta-Analysis

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Liu, Fen ^a   Wang, Xiwei ^a   Wu, Gang ^b   Chen, Ling ^a   Hu, Peng ^a   Ren, Hong ^a   Hu, Huaidong ^a  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COFFEE; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; DRINKING BEHAVIOR; HEPATITIS C VIRUS; HONG KONG; HUMAN; ITALY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER PROTECTION; POPULATION RESEARCH; RISK REDUCTION; UNITED STATES; META ANALYSIS; PROTECTION;

COFFEE;

COFFEE; HUMANS; LIVER CIRRHOSIS; PROTECTIVE FACTORS;

EID: 84953267203     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142457     Document Type: Article

References (50)

1. Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am Fam Physician. 2006; 74(5):756-62. .
2. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004; 127(5 Suppl 1):S35-50. .
3. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 1993; 328(25):1828-35. doi: 10.1056/NEJM199306243282508 .
4. Hui AY, Friedman SL. Molecular basis of hepatic fibrosis. Expert reviews in molecular medicine. 2003; 5(5):1-23. doi: 10.1017/S1462399403005684 .
5. Chu CM, Liaw YF. Hepatitis B virus-related cirrhosis: natural history and treatment. Semin Liver Dis. 2006; 26(2):142-52. Epub 2006/05/05. doi: 10.1055/s-2006-939752 .
6. Larter CZ, Yeh MM, Haigh WG, Van Rooyen DM, Brooling J, Heydet D, et al. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease. Obesity. 2013; 21 (6):1189-99. doi: 10.1002/oby.20123 .
7. White DL, Richardson PA, Al-Saadi M, Fitzgerald SJ, Green L, Amaratunge C, et al. Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection. Dig Dis Sci. 2011; 56(6):1835-47. doi: 10.1007/s10620-010-1505-x
8. Casiglia E, Spolaore P, Ginocchio G, Ambrosio GB. Unexpected effects of coffee consumption on liver enzymes. European journal of epidemiology. 1993; 9(3):293-7. .
9. Honjo S, Kono S, Coleman MP, Shinchi K, Sakurai Y, Todoroki I, et al. Coffee consumption and serum aminotransferases in middle-Aged Japanese men. J Clin Epidemiol. 2001; 54(8):823-9. .
10. Tanaka K, Tokunaga S, Kono S, Tokudome S, Akamatsu T, Moriyama T, et al. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. International journal of epidemiology. 1998; 27(3):438-43. Epub 1998/08/11. .
11. Bravi F, Bosetti C, Tavani A, Bagnardi V, Gallus S, Negri E, et al. Coffee drinking and hepatocellular carcinoma risk: A meta-Analysis. Hepatology. 2007; 46(2):430-5. doi: 10.1002/hep.21708 .
12. Bravi F, Bosetti C, Tavani A, Gallus S, La Vecchia C. Coffee reduces risk for hepatocellular carcinoma: An updated meta-Analysis. Clinical gastroenterology and hepatology: The official clinical practice journal of the American Gastroenterological Association. 2013; 11(11):1413-21 e1. doi: 10.1016/j.cgh.2013. 04.039 .
13. Anty R, Marjoux S, Iannelli A, Patouraux S, Schneck A-S, Bonnafous S, et al. Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. Journal of Hepatology. 2012; 57(5):1090-6. doi: 10.1016/j.jhep.2012.07.014
14. Corrao G, Zambon A, Bagnardi V, D'Amicis A, Klatsky A, Collaborative SG. Coffee, caffeine, and the risk of liver cirrhosis. Annals of epidemiology. 2001; 11(7):458-65. doi: 10.1016/s1047-2797(01)00223-x
15. Costentin CE, Roudot-Thoraval F, Zafrani E-S, Medkour F, Pawlotsky J-M, Mallat A, et al. Association of caffeine intake and histological features of chronic hepatitis C. Journal of Hepatology. 2011; 54 (6):1123-9. doi: 10.1016/j.jhep.2010.08.027
16. Wang X, Liu F, Wei F, Ren H, Hu H. Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: A meta-Analysis. PLoS One. 2014; 9(6):e100128. doi: 10.1371/journal. pone.0100128
17. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-Analyses. European journal of epidemiology. 2010; 25(9):603-5. doi: 10. 1007/s10654-010-9491-z
18. Mantel N, HaenszelW. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22(4):719-48. .
19. DerSimonian R, Laird N. Meta-Analysis in clinical trials. Controlled clinical trials. 1986; 7(3):177-88. .
20. Higgins J. Green S. Cochrane handbook for systematic reviews of interventions version 5.1. 0. The Cochrane Collaboration. 2011; 5(0).
21. Hedges LV, Pigott TD. The power of statistical tests in meta-Analysis. Psychological methods. 2001; 6 (3):203-17. .
22. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Statistics in medicine. 1988; 7(8):889-94. .
23. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-Analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997; 315(7109):629-34
24. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50(4):1088-101. .
25. Corrao G, Lepore AR, Torchio P, Valenti M, Galatola G, D'Amicis A, et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease. European journal of epidemiology. 1994; 10(6):657-64. Epub 1994/12/01. .
26. Gallus S, Tavani A, Negri E, La Vecchia C. Does coffee protect against liver cirrhosis? Annals of epidemiology. 2002; 12(3):202-5. .
27. Stroffolini T, Cotticelli G, Medda E, Niosi M, Del Vecchio-Blanco C, Addolorato G, et al. Interaction of alcohol intake and cofactors on the risk of cirrhosis. Liver International. 2010; 30(6):867-70. doi: 10. 1111/j.1478-3231.2010.02261.x
28. Triantos C, Manolakopoulos S, Smirnidis A, Vlachogiannakos J, Goulis J, Kalafateli M, et al. Is caffeine responsible for the hepatoprotective effect of coffee consumption in patients with chronic liver diseases? A multicentre study. Gastroenterology. 2013; 1):S1008. .
29. Walton HB, Masterton GS, Hayes PC. An epidemiological study of the association of coffee with chronic liver disease. Scottish medical journal. 2013; 58(4):217-22. Epub 2013/11/12. doi: 10.1177/0036933013507869 .
30. Khalaf N, White D, Kanwal F, Ramsey D, Mittal S, Tavakoli-Tabasi S, et al. Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C. Clinical gastroenterology and hepatology: The official clinical practice journal of the American Gastroenterological Association. 2015. doi: 10.1016/j.cgh.2015.01.030 .
31. Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med. 2006; 166(11):1190-5. Epub 2006/06/15. doi: 10.1001/archinte.166.11.1190 .
32. Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, et al. Coffee Intake Is Associated with Lower Rates of Liver Disease Progression in Chronic Hepatitis C. Hepatology. 2009; 50(5):1360-9. doi: 10.1002/hep.23162
33. Modi AA, Feld JJ, Park Y, Kleiner DE, Everhart JE, Liang TJ, et al. Increased Caffeine Consumption Is Associated with Reduced Hepatic Fibrosis. Hepatology. 2010; 51(1):201-9. doi: 10.1002/hep.23279
34. Ong A, Wong VWS, Wong GLH, Chan HLY. The effect of caffeine and alcohol consumption on liver fibrosis-A study of 1045 Asian hepatitis B patients using transient elastography. Liver International. 2011; 31(7):1047-53. 92. doi: 10.1111/j.1478-3231.2011.02555.x
35. Bambha K, Wilson LA, Unalp A, Loomba R, Neuschwander-Tetri BA, Brunt EM, et al. Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. Liver International. 2014; 34(8):1250-8. doi: 10.1111/liv.12379
36. El-Serag H, Kuzniarek J, Ramsey DJ, Tabasi ST, White DL, Kanwal F. Beverage intake and the risk of advanced fibrosis in HCV: Coffee, tea, or sodas? Gastroenterology. 2014; 1):S129-S30. .
37. Machado SR, Parise ER, de Carvalho L. Coffee has hepatoprotective benefits in Brazilian patients with chronic hepatitis C even in lower daily consumption than in American and European populations. Brazilian Journal of Infectious Diseases. 2014; 18(2):170-6. 36. doi: 10.1016/j.bjid.2013.09. 001
38. Shim SG, Jun DW, Kim EK, Saeed WK, Lee KN, Lee HL, et al. Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model. J Gastroenterol Hepatol. 2013; 28 (12):1877-84. doi: 10.1111/jgh.12317 .
39. Moreno MG, Chavez E, Aldaba-Muruato LR, Segovia J, Vergara P, Tsutsumi V, et al. Coffee prevents CCl(4)-induced liver cirrhosis in the rat. Hepatol Int. 2011; 5(3):857-63. doi: 10.1007/s12072-010-9247-6 .
40. Esposito F, Morisco F, Verde V, Ritieni A, Alezio A, Caporaso N, et al. Moderate coffee consumption increases plasma glutathione but not homocysteine in healthy subjects. Alimentary pharmacology & therapeutics. 2003; 17(4):595-601. .
41. Vitaglione P, Morisco F, Mazzone G, Amoruso DC, Ribecco MT, Romano A, et al. Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins. Hepatology. 2010; 52(5):1652-61. Epub 2010/11/03. doi: 10.1002/hep.23902 .
42. Dranoff JA, Feld JJ, Lavoie EG, Fausther M. How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations. Hepatology. 2014; 60(2):464-7. 18. doi: 10.1002/hep.27032
43. Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2005; 128(1):24-32. .
44. Kono S, Shinchi K, Imanishi K, Todoroki I, Hatsuse K. Coffee and serum gamma-glutamyltransferase: A study of self-defense officials in Japan. Am J Epidemiol. 1994; 139(7):723-7. .
45. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38(2):518-26. doi: 10.1053/jhep.2003.50346 .
46. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study. Lancet. 2001; 357 (9262):1069-75. doi: 10.1016/S0140-6736(00)04258-6 .
47. Larsson SC, Wolk A. Coffee consumption and risk of liver cancer: A meta-Analysis. Gastroenterology. 2007; 132(5):1740-5. doi: 10.1053/j.gastro.2007.03.044 .
48. Hasegawa M, Yamada S, Hirayama C. Fasting plasma caffeine level in cirrhotic patients: relation to plasma levels of catecholamines and renin activity. Hepatology. 1989; 10(6):973-7. .
49. Tokunaga S, Hirohata T, Hirohata I. Reproducibility of dietary and other data from a self-Administered questionnaire. Environmental health perspectives. 1994; 102 Suppl 8:5-10
50. Hu FB, Rimm E, Smith-Warner SA, Feskanich D, Stampfer MJ, Ascherio A, et al. Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. The American journal of clinical nutrition. 1999; 69(2):243-9.